Filing Details
- Accession Number:
- 0001209191-14-034297
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-15 17:09:52
- Reporting Period:
- 2014-05-13
- Filing Date:
- 2014-05-15
- Accepted Time:
- 2014-05-15 17:09:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1423824 | Alder Biopharmaceuticals Inc | ALDR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1599970 | Partnership Limited 8 West Ventures | C/O Five Corners Capital 700 W. Georgia Street, Suite 2500 Vancouver A1 V7Y1B3 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-13 | 3,219,528 | $0.00 | 3,219,528 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-05-13 | 250,000 | $10.00 | 3,469,528 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2014-05-13 | 1,027,668 | $0.00 | 1,027,668 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2014-05-13 | 853,146 | $0.00 | 853,146 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2014-05-13 | 841,750 | $0.00 | 841,750 | $0.00 |
| Common Stock | Series D Preferred Stock | Disposition | 2014-05-13 | 496,964 | $0.00 | 496,964 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The preferred stock converted into common stock on a 1-for-1 basis upon the closing of the issuer's initial public offering and had no expiration date.
Billionaire Hedge Funds
